Cited by 37Medicinal Plants and NeuroprotectionNatural product bioactivities and synthesisPhytochemicals and Medicinal Plants

Recent insights into therapeutic potential and nanostructured carrier systems of Centella asiatica: An evidence-based review

Open access
Bansal, Keshav, Bhati, Hemant, Vanshita, Bajpai, Meenakshi·2024·Pharmacological Research - Modern Chinese Medicine

Abstract

: Centella asiatica (L.) Urb. is an authentic herbal medicine that is frequently used in Southeast Asian regions and scientific investigations have demonstrated the benefits of Centella asiatica and its constituents in various health issues. The active constituents of Centella asiatica are pentacyclic triterpenoid (asiatic acid, adecassic acid, madecassoside, and asiaticoside) and saponins. : The study includes a thorough review of prior research findings of an assortment of sources is used to gather data on its therapeutic potential and novel delivery approaches of C. asiatica. This review outlines evidence-based recent updates on the potential therapeutic actions and various nanocarrier types that are employed to deliver the actives of Centella asiatica to address the issues of poor stability, limited bioavailability, and higher metabolism, providing a new way to utilize these bioactive as a first-line treatment for various disorders. : The findings revealed that C. asiatica possesses a broad array of therapeutic effects including anti-ulcer, anti-cancer, anti-diabetic, anti-osteoporotic, neuroprotective, antioxidant, cardioprotective, and anti-inflammatory activities. Further, various approaches have been examined to overcome these constraints with the development of novel carrier systems including nanoparticles, polymeric nanocarriers, transferosomes, nanoemulsions, nanosuspensions, liposomes, hydrogels, microneedles, and micelles. : The study involves the importance of C. asiatica as a potential natural resource with a wide range of traditional uses. Its medicinal properties, which include the ability to treat chronic illnesses like cancer as well as fight infections, emphasize the importance of this plant in modern medicine. Future studies should prioritize in vivo and in vitro clinical trials to broaden the understanding of the mechanism involved as well as the development of more advanced delivery approaches in order to improve its utilization in healthcare.

Integrity signals

Registry

Crossref · 10.1016/j.prmcm.2024.100403

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Preclinical and pharmacokinetic studies indicate that triterpenoid-rich extracts exhibit dose-dependent biological activity despite inherently low bioavailability, supporting the rationale for a moderate dosing strategy.

    “In addition, preclinical and pharmacokinetic studies indicate that triterpenoid-rich extracts exhibit dose-dependent biological activity despite inherently low bioavailability, supporting the rationale for a moderate dosing strategy [25,53,54,55,56,57].”
  • In traditional medicine, Centella asiatica has been employed as tea or decoctions for diverse dermatological conditions, including wounds, burns, scars, eczema, psoriasis, and varicose ulcers.

    “In traditional medicine, it has been employed as tea or decoctions for diverse dermatological conditions, including wounds, burns, scars, eczema, psoriasis, and varicose ulcers (Bansal et al. 2024).”
  • Bansal et al. (2024) did not specifically dissect dermatological anti-aging mechanisms or the impact of formulation architectures on skin-related outcomes.

    “Bansal et al. (2024) offered a broad therapeutic survey spanning anti-ulcer, anti-cancer, anti-diabetic, neuroprotective, and cardioprotective activities, alongside nanostructured carrier systems, but did not specifically dissect dermatological anti-aging mechanisms or the impact of formulation architectures on skin-related outcomes.”
  • Bansal et al. (2024) offered a broad therapeutic survey spanning anti-ulcer, anti-cancer, anti-diabetic, neuroprotective, and cardioprotective activities, alongside nanostructured carrier systems.

    “Bansal et al. (2024) offered a broad therapeutic survey spanning anti-ulcer, anti-cancer, anti-diabetic, neuroprotective, and cardioprotective activities, alongside nanostructured carrier systems, but did not specifically dissect dermatological anti-aging mechanisms or the impact of formulation architectures on skin-related outcomes.”

The citation lists haven’t been fetched yet

References 134 · Cited by 37

Authors
Bansal, K., Bhati, H., Vanshita, & Bajpai, M.
Affiliations
GLA University (IN)
Corresponding author
Vanshita
Venue
Pharmacological Research - Modern Chinese Medicine
Publisher
Elsevier BV
Published
2024-03
Volume
10
Pages
100403
ISSN
2667-1425 (ISSN-L)
OpenAlex
W4392094167
Cited by
37
References
134
Citations by year
2026: 12 · 2025: 15 · 2024: 9
FWCI
17.93
Type
journal article
Language
en
Open access
Locations
  • Pharmacological Research - Modern Chinese Medicine (publishedVersion, cc-by-nc)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
GLA University
Topics
  • Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Neuroprotection
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Natural product bioactivities and synthesis
  • Health Sciences › Medicine › Complementary and alternative medicine › Phytochemicals and Medicinal Plants
Keywords
Centella asiatica, pentacyclic triterpenes, asiatic acid, madecassoside, saponins, bioactive compound delivery, nanocarriers, bioavailability enhancement, anti-inflammatory activity, anticancer activity, antidiabetic activity, antioxidant activity, neuroprotection, cardioprotection, osteoporosis, herbal medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review